Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients

Gerald F. Watts, Alberico L. Catapano, Luis Masana, Alberto Zambon, Angela Pirillo, Lale Tokgözoglu

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


The widespread use of statins has largely improved the treatment of hypercholesterolemia, but many patients still fail to achieve the LDL-C targets recommended by guidelines. Furthermore, some patients continue to present a very high cardiovascular (CV) risk or even an extreme risk despite being well treated, mainly due to the presence of co-morbidities such as diabetes or peripheral artery disease, which significantly increase their global CV risk. For these very high CV risk patients, the most recent European guidelines have reviewed the LDL-C goals and recommend an LDL-C reduction of at least 50% and a goal of

Original languageEnglish
Pages (from-to)e30-e34
JournalAtherosclerosis Supplements
Publication statusPublished - Dec 2020


Dive into the research topics of 'Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients'. Together they form a unique fingerprint.

Cite this